Allozen Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 15-06-2024
- Paid Up Capital ₹ 4.50 M
as on 15-06-2024
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.20 Cr
as on 15-06-2024
- Revenue 25.91%
(FY 2023)
- Profit -49.85%
(FY 2023)
- Ebitda 67.72%
(FY 2023)
- Net Worth 25.31%
(FY 2023)
- Total Assets 58.32%
(FY 2023)
About Allozen Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹24.20 Cr.
Prafful Jain and Atish Jain serve as directors at the Company.
- CIN/LLPIN
U24290KA2019PTC128784
- Company No.
128784
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Allozen Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prafful Jain  | Director | 16-Oct-2019 | Current |
| Atish Jain | Director | 01-Oct-2022 | Current |
Financial Performance of Allozen Pharma.
Allozen Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.91% increase. The company also saw a substantial fall in profitability, with a 49.85% decrease in profit. The company's net worth Soared by an impressive increase of 25.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Allozen Pharma?
In 2023, Allozen Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 30 Jun 2022 | ₹14.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 30 Jun 2022 | ₹2.00 M | Open |
Others Creation Date: 27 Feb 2020 | ₹10.00 Cr | Open |
How Many Employees Work at Allozen Pharma?
Allozen Pharma has a workforce of 26 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Allozen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allozen Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
